Universal Cables Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 29, 2025, 10:54 pm

Quick Insight

Universal Cables Ltd currently trades at ₹763 with a market capitalization of ₹2,646 Cr and a P/E ratio of 22.7, which is slightly above the industry average in India. The company's Return on Equity (ROE) stands at 5.06%, while Return on Capital Employed (ROCE) is at 8.58%, indicating room for improvement compared to sector peers. Universal Cables Ltd has a healthy Operating Profit Margin (OPM) of 10%, reflecting efficient cost management. With 61.89% promoter holding and a stable financial structure with reserves of ₹1,737 Cr and manageable borrowings of ₹849 Cr, the company enjoys a strong foundation.

However, Universal Cables Ltd faces risks due to its low ROE and ROCE figures, which suggest underutilization of capital and potential inefficiencies in operations. The Current Credit Cycle (CCC) of 153 days is relatively high, impacting cash flow efficiency. The Price-to-Book Value (P/BV) ratio of 0.96x indicates the stock may be undervalued compared to its intrinsic worth, providing an opportunity for investors. Looking ahead, improving operational efficiency, reducing CCC, and enhancing profitability could bolster the company's performance. Conversely, a failure to address capital allocation issues and operational inefficiencies may hinder growth prospects.

In conclusion, while Universal Cables Ltd demonstrates financial stability and efficient cost management, optimizing capital utilization and enhancing operational performance will be crucial for unlocking its full potential and delivering sustainable value to shareholders in the competitive cables industry in India.

Competitors of Universal Cables Ltd

All Competitor Stocks of Universal Cables Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:45 am

Below is a detailed analysis of the quarterly data for Universal Cables Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 600.00 Cr.. The value appears to be declining and may need further review. It has decreased from 674.00 Cr. (Mar 2025) to 600.00 Cr., marking a decrease of 74.00 Cr..
• For Expenses, as of Jun 2025, the value is 542.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 612.00 Cr. (Mar 2025) to 542.00 Cr., marking a decrease of 70.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 10.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 15.00 Cr..
• For Interest, as of Jun 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 25.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 45.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Mar 2025) to 45.00 Cr., marking a decrease of 20.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 28.00%, marking an increase of 5.00%.
• For Net Profit, as of Jun 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2025) to 33.00 Cr., marking a decrease of 17.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.49. The value appears to be declining and may need further review. It has decreased from 14.32 (Mar 2025) to 9.49, marking a decrease of 4.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:35 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: September 10, 2025, 2:44 pm

Below is a detailed analysis of the balance sheet data for Universal Cables Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 35.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,740.00 Cr. (Mar 2024) to 1,737.00 Cr., marking a decrease of 3.00 Cr..
• For Borrowings, as of Mar 2025, the value is 849.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 771.00 Cr. (Mar 2024) to 849.00 Cr., marking an increase of 78.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 799.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 774.00 Cr. (Mar 2024) to 799.00 Cr., marking an increase of 25.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,419.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,320.00 Cr. (Mar 2024) to 3,419.00 Cr., marking an increase of 99.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 255.00 Cr.. The value appears strong and on an upward trend. It has increased from 200.00 Cr. (Mar 2024) to 255.00 Cr., marking an increase of 55.00 Cr..
• For CWIP, as of Mar 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 35.00 Cr..
• For Investments, as of Mar 2025, the value is 1,618.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,652.00 Cr. (Mar 2024) to 1,618.00 Cr., marking a decrease of 34.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,511.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,467.00 Cr. (Mar 2024) to 1,511.00 Cr., marking an increase of 44.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,419.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,320.00 Cr. (Mar 2024) to 3,419.00 Cr., marking an increase of 99.00 Cr..

Notably, the Reserves (1,737.00 Cr.) exceed the Borrowings (849.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Universal Cables Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 25.76. This value is within the healthy range. It has decreased from 31.19 (Mar 24) to 25.76, marking a decrease of 5.43.
• For Diluted EPS (Rs.), as of Mar 25, the value is 25.76. This value is within the healthy range. It has decreased from 31.19 (Mar 24) to 25.76, marking a decrease of 5.43.
• For Cash EPS (Rs.), as of Mar 25, the value is 20.32. This value is within the healthy range. It has increased from 16.69 (Mar 24) to 20.32, marking an increase of 3.63.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 510.69. It has decreased from 511.57 (Mar 24) to 510.69, marking a decrease of 0.88.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 510.69. It has decreased from 511.57 (Mar 24) to 510.69, marking a decrease of 0.88.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 694.09. It has increased from 582.35 (Mar 24) to 694.09, marking an increase of 111.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 58.34. This value is within the healthy range. It has increased from 53.40 (Mar 24) to 58.34, marking an increase of 4.94.
• For PBIT / Share (Rs.), as of Mar 25, the value is 50.46. This value is within the healthy range. It has increased from 46.56 (Mar 24) to 50.46, marking an increase of 3.90.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.53. This value is within the healthy range. It has increased from 20.19 (Mar 24) to 20.53, marking an increase of 0.34.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 12.44. This value is within the healthy range. It has increased from 9.85 (Mar 24) to 12.44, marking an increase of 2.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 25.76. This value is within the healthy range. It has decreased from 31.19 (Mar 24) to 25.76, marking a decrease of 5.43.
• For PBDIT Margin (%), as of Mar 25, the value is 8.40. This value is below the healthy minimum of 10. It has decreased from 9.16 (Mar 24) to 8.40, marking a decrease of 0.76.
• For PBIT Margin (%), as of Mar 25, the value is 7.27. This value is below the healthy minimum of 10. It has decreased from 7.99 (Mar 24) to 7.27, marking a decrease of 0.72.
• For PBT Margin (%), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 10. It has decreased from 3.46 (Mar 24) to 2.95, marking a decrease of 0.51.
• For Net Profit Margin (%), as of Mar 25, the value is 1.79. This value is below the healthy minimum of 5. It has increased from 1.69 (Mar 24) to 1.79, marking an increase of 0.10.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 8. It has decreased from 5.35 (Mar 24) to 3.71, marking a decrease of 1.64.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.04. This value is below the healthy minimum of 15. It has decreased from 6.09 (Mar 24) to 5.04, marking a decrease of 1.05.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.93. This value is below the healthy minimum of 10. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
• For Return On Assets (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 5. It has decreased from 3.26 (Mar 24) to 2.61, marking a decrease of 0.65.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.11 (Mar 24) to 0.21, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.47, marking an increase of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.71. It has increased from 0.65 (Mar 24) to 0.71, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.60, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.16 (Mar 24) to 1.15, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.23. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 5.23, marking an increase of 0.16.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 9.61 (Mar 24) to 0.00, marking a decrease of 9.61.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.88 (Mar 24) to 0.00, marking a decrease of 7.88.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 90.39 (Mar 24) to 0.00, marking a decrease of 90.39.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.12 (Mar 24) to 0.00, marking a decrease of 92.12.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.95. This value is below the healthy minimum of 3. It has decreased from 2.03 (Mar 24) to 1.95, marking a decrease of 0.08.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 3. It has increased from 1.37 (Mar 24) to 1.42, marking an increase of 0.05.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,553.77. It has increased from 2,340.69 (Mar 24) to 2,553.77, marking an increase of 213.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.16 (Mar 24) to 1.06, marking a decrease of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 12.62. This value is within the healthy range. It has decreased from 12.63 (Mar 24) to 12.62, marking a decrease of 0.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.71, marking a decrease of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 90.38 (Mar 24) to 0.00, marking a decrease of 90.38.
• For Price / BV (X), as of Mar 25, the value is 0.96. This value is below the healthy minimum of 1. It has increased from 0.88 (Mar 24) to 0.96, marking an increase of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.71, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness